Hidradenitis Suppurativa Clinical Trials

17 studies are recruiting for hidradenitis suppurativa in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies now recruiting

1. A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

   Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Up0122 105, Santa Monica, California

   Locations

   14 in total

   Run by

   UCB Biopharma SRL

   See if you can join NCT06888193 on ClinicalTrials.gov

2. Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa

   The purpose of this study is to evaluate the maximal use of ruxolitinib cream in adult and adolescent participants with hidradenitis suppurativa.

   Stage

   Phase 1

   Ages

   12 to 75

   Site

   Saguaro Dermatology, Phoenix, Arizona

   Locations

   21 in total

   Run by

   Incyte Corporation

   See if you can join NCT07049575 on ClinicalTrials.gov

3. An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

   The purpose of this study is to evaluate the long-term safety, tolerability and efficacy of remibrutinib (LOU064) in adult participants with moderate to severe hidradenitis suppurativa (HS) who have completed either of the preceding Phase 3 studies, CLOU064J12301 or CLOU064J12302.

   Stage

   Phase 3

   Ages

   18 to 100

   Site

   Johnson Dermatology, Fort Smith, Arkansas

   Locations

   20 in total

   Run by

   Novartis Pharmaceuticals

   See if you can join NCT07665437 on ClinicalTrials.gov

4. Targeting Nociceptors in Hidradenitis Suppurativa

   This study will build on data from mice and humans implicating TRPV1 nociceptors in the pathogenesis of the type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin r…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University of Massachusetts Chan Medical School, Worcester, Massachusetts

   Run by

   University of Massachusetts, Worcester

   See if you can join NCT05403710 on ClinicalTrials.gov

5. Capsule Microbiota Transplant Therapy for Hidradenitis Suppurativa

   HS is relatively common in the United States with a prevalence of 0.1-1.0%. 1 HS has a dramatic impact on quality of life, significantly more so than other chronic skin diseases, such as psoriasis or atopic dermatitis (AD). HS also has a large economic impact, due to frequent emergency department a…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   University of Minnesota, Minneapolis, Minnesota

   Run by

   University of Minnesota

   See if you can join NCT06058520 on ClinicalTrials.gov

6. A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

   This is a multinational, randomized, double-blind, placebo-controlled, Phase 2, dose finding study to evaluate the efficacy and safety of different doses of SAR445399 in adult participants with moderate to severe hidradenitis suppurativa. The purpose of this study is to assess the efficacy and safe…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Scottsdale Clinical Trials- Site Number : 8400006, Scottsdale, Arizona

   Locations

   67 in total

   Run by

   Sanofi

   See if you can join NCT07225569 on ClinicalTrials.gov

7. Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.

   This study is to investigate the efficacy of siplizumab in the treatment of Hidradenitis Suppurativa.

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   University of Alabama at Birmingham, Birmingham, Alabama

   Run by

   University of Alabama at Birmingham

   See if you can join NCT06326476 on ClinicalTrials.gov

8. Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

   This is a Phase 2b, global, multicenter, sequential, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study in participants with moderate to severe hidradenitis suppurativa. The purpose of the main study is to assess the efficacy and safety of brivekimig in a dose-ranging …

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Medical Dermatology Specialists - Site Number: 8400019, Phoenix, Arizona

   Locations

   79 in total

   Run by

   Sanofi

   See if you can join NCT07170917 on ClinicalTrials.gov

9. Regulation of Inflammatory Genes in Hidradenitis Suppurativa

   The purpose of this protocol is to examine the cytokine profi le of pati ents with hidradeniti s suppurati va (HS) and idemechanisms responsible for post-transcripti onal regulati on of these genes. The primary objecti ve is to determinfollowing cytokines linked to hidradeniti s suppurati va are di…

   Stage

   Not phased

   Ages

   18 to 89

   Site

   Whitaker Clinic, Birmingham, Alabama

   Run by

   University of Alabama at Birmingham

   See if you can join NCT05507125 on ClinicalTrials.gov

10. Myriad™ Augmented Soft Tissue Reconstruction Registry

    This is an observational study designed to evaluate the safety and clinical outcomes of Myriad™ in soft tissue reconstruction procedures. The study will enroll participants who are undergoing a surgical procedure, where the attending physician will use Myriad™ as part of the surgical intervention.

    Stage

    Not phased

    Ages

    18 and older

    Site

    Asencion Sacred Heart, Pensacola, Florida

    Locations

    15 in total

    Run by

    Aroa Biosurgery Limited

    See if you can join NCT05243966 on ClinicalTrials.gov

11. Clinical and Biological Characteristics of Hidradenitis Suppurativa

    Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively charact…

    Stage

    Not phased

    Ages

    13 and older

    Site

    University of California, San Francisco, San Francisco, California

    Run by

    University of California, San Francisco

    See if you can join NCT03967600 on ClinicalTrials.gov

12. Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository

    Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively charact…

    Stage

    Not phased

    Ages

    10 and older

    Site

    University of California San Francisco, San Francisco, California

    Run by

    University of California, San Francisco

    See if you can join NCT04115566 on ClinicalTrials.gov

13. A Study of Zasocitinib in Adults With Hidradenitis Suppurativa

    Hidradenitis Suppurativa (HS) is a skin condition that causes deep, painful bumps on the skin. These bumps usually appear in an area where the skin rubs together. They start as small bumps but may become swollen and red over time. If they fill with pus, these lumps are called abscesses; these can a…

    Stage

    Phase 2

    Ages

    18 and older

    Site

    Johnson Dermatology, Fort Smith, Arkansas

    Locations

    49 in total

    Run by

    Takeda

    See if you can join NCT07244263 on ClinicalTrials.gov

14. The Ohio State University Dermatology Biorepository

    This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.

    Stage

    Not phased

    Ages

    Any age

    Site

    OSU Dermatology West, Columbus, Ohio

    Run by

    Ohio State University

    See if you can join NCT03146676 on ClinicalTrials.gov

15. A Study for Evaluating Safety & Efficacy of Topical Roflumilast 0.3% Foam in Hidradenitis Suppurativa

    This is a phase 2a, open label study. As psoriasis and Hidradenitis Suppurativa (HS) share multiple inflammatory pathways, the investigators hypothesize that the use of topical roflumilast 0.3% foam is a safe and efficacious option as a monotherapy for patients with mild disease and as add-on thera…

    Stage

    Phase 2

    Ages

    18 to 90

    Site

    Lakeview Hospital, Covington, Louisiana

    Locations

    4 in total

    Run by

    Tulane University

    See if you can join NCT07077902 on ClinicalTrials.gov

16. A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

    Hidradenitis suppurativa (HS) and atopic dermatitis (AD) are chronic inflammatory skin diseases that lead to the development of skin lesions and symptoms such as pain and discomfort. The purpose of this study is to assess molecular changes in adult participants with moderate to severe HS or with mo…

    Stage

    Phase 2

    Ages

    18 to 75

    Site

    Physioseq, LLC /ID# 267266, Sacramento, California

    Locations

    2 in total

    Run by

    AbbVie

    See if you can join NCT06524635 on ClinicalTrials.gov

17. Battlefield Acupuncture for Pain in Hidradenitis Suppurativa

    The investigators will investigate battlefield acupuncture as a treatment for the pain of hidradenitis suppurativa.

    Stage

    Not phased

    Ages

    18 and older

    Site

    WSUPG Dermatology, Dearborn, Michigan

    Run by

    Wayne State University

    See if you can join NCT04218422 on ClinicalTrials.gov